Response to Tyrosine Kinase Inhibitors in Real-World Patients With Chronic Myeloid Leukemia. - Szeto AH; Bucci T; Deal A; Zhu A; Ahmad M; Cass AS; Sketch MR; Kemper R; Zeidner JF; Foster MC; Muluneh B; Crona DJ (The Annals of pharmacotherapy, 2022)